Oncology Pharma Inc (ONPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2018 | 03-2007 | 03-2004 | 03-2003 | 03-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | 1,340 | 2,930 |
| Receivables | N/A | N/A | N/A | 170 | 60 |
| Other current assets | 0 | 0 | 20 | 60 | 110 |
| TOTAL | $N/A | $N/A | $20 | $1,570 | $3,100 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 120 | 500 |
| Other Non-Current Assets | 0 | 0 | 0 | 40 | 8 |
| TOTAL | $N/A | $N/A | $N/A | $160 | $508 |
| Total Assets | $N/A | $N/A | $20 | $1,750 | $3,610 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 190 | 730 | 900 |
| Other current liabilities | N/A | N/A | 0 | 140 | 330 |
| TOTAL | $N/A | $N/A | $210 | $870 | $1,230 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $N/A | $210 | $870 | $1,230 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 10 | 9 | 9 |
| Retained earnings | N/A | N/A | N/A | -24,000 | -22,480 |
| Other shareholders' equity | 0 | 0 | 0 | 1 | 91 |
| TOTAL | $N/A | $N/A | $25,390 | $870 | $2,370 |
| Total Liabilities And Equity | $0 | $0 | $25,600 | $1,740 | $3,600 |